Find policies, billing codes, payers, states, and providers
CPT 67228: Laser Photocoagulation for Proliferative Retinopathy
CPT code 67228 covers laser photocoagulation aimed at destroying proliferative neovascularization and fibrous tissue in the retina, a sight‑threatening complication most commonly seen in diabetic retinopathy. Nationally, this procedure is an established, vision‑preserving intervention with implications for outpatient ophthalmology capacity, access to specialty retina care, and payer coverage policies. Major payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. This publication provides a clinical and billing overview of 67228, contextualizes the code within related retinal procedure codes, and outlines typical sites of service and service type. Readers will find: concise clinical context for when laser photocoagulation is used, comparisons to adjacent CPT codes for retinal destruction, common payer coverage considerations, and operational implications for ophthalmology practices and ambulatory surgery centers. The summary serves as a reference for coding teams, practice managers, and clinical leaders seeking a clear, national perspective on the use and billing of retinal laser treatment for proliferative retinopathy.
Customize your policy alerts
Sign up for cpt 67228 policy alerts
Get alerted when payer policies referencing 67228 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 67228 describes the use of laser photocoagulation to destroy abnormally proliferating retinal blood vessels and adjacent fibrous tissue, a treatment commonly applied for proliferative retinopathy such as diabetic retinopathy. The procedure targets neovascularization within the retina and may address extension of fibrous proliferation toward the optic nerve and vitreous to reduce risk of vision loss.
Service type: Laser retinal photocoagulation for proliferative retinopathy
Typical site of service: Outpatient ophthalmology clinic or ambulatory surgery center, where retinal laser procedures are performed under local or topical anesthesia.
National Reimbursement Benchmarks
Commercial averages sit well above Medicare for CPT 67228: Blue Cross Blue Shield and UnitedHealth Group show mean rates near $889 and $726.10 respectively, while BUCA’s mean of $768.20 is notably higher than Medicare’s mean of $352.20, indicating a substantial gap between average commercial reimbursement and the Medicare baseline.
Rate dispersion (P75 minus P25) highlights variability across payers. Blue Cross Blue Shield has a wide interquartile spread of $627.00 ($1,170.00 - $514.30), and UnitedHealth Group is also broad at $562.30 ($964.50 - $400.20). By contrast, Aetna’s IQR is $360.40 ($521.40 - $146.00) and Cigna’s is $552.00 ($953.00 - $401.30). BUCA’s IQR is $573.00 ($1,017.00 - $429.30), while Medicare’s tighter spread is $31.00 ($363.00 - $332.00), making Medicare the tightest and Blue Cross Blue Shield the widest among these payers.